Toggle Main Menu Toggle Search

Open Access padlockePrints

The contributions of mitochondrial and nuclear mitochondrial genetic variation to neuroticism

Lookup NU author(s): Dr Sarah PickettORCiD, Professor Gavin Hudson

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2023, The Author(s).Neuroticism is a heritable trait composed of separate facets, each conferring different levels of protection or risk, to health. By examining mitochondrial DNA in 269,506 individuals, we show mitochondrial haplogroups explain 0.07-0.01% of variance in neuroticism and identify five haplogroup and 15 mitochondria-marker associations across a general factor of neuroticism, and two special factors of anxiety/tension, and worry/vulnerability with effect sizes of the same magnitude as autosomal variants. Within-haplogroup genome-wide association studies identified H-haplogroup-specific autosomal effects explaining 1.4% variance of worry/vulnerability. These H-haplogroup-specific autosomal effects show a pleiotropic relationship with cognitive, physical and mental health that differs from that found when assessing autosomal effects across haplogroups. We identify interactions between chromosome 9 regions and mitochondrial haplogroups at P < 5 × 10−8, revealing associations between general neuroticism and anxiety/tension with brain-specific gene co-expression networks. These results indicate that the mitochondrial genome contributes toward neuroticism and the autosomal links between neuroticism and health.


Publication metadata

Author(s): Xia C, Pickett SJ, Liewald DCM, Weiss A, Hudson G, Hill WD

Publication type: Article

Publication status: Published

Journal: Nature Communications

Year: 2023

Volume: 14

Issue: 1

Online publication date: 30/05/2023

Acceptance date: 04/05/2023

Date deposited: 13/06/2023

ISSN (electronic): 2041-1723

Publisher: Nature Research

URL: https://doi.org/10.1038/s41467-023-38480-y

DOI: 10.1038/s41467-023-38480-y

Data Access Statement: UK Biobank data used in this study are available via the UK Biobank data access process (see http://www.ukbiobank.ac.uk/register-apply/). The Summary statistics for MT associations are available in Supplementary Data 4-6, Summary statistics for the autosomal associations are available through GWAS catalog at https://www.ebi.ac.uk/gwas/ under accession codes GCST90264121, GCST90264122, GCST90264123, GCST90264124, GCST90264125, GCST90264126, GCST90264127, GCST90264128, GCST90264129, GCST90264130, GCST90264131, GCST90264132, GCST90264133, GCST90264134, GCST90264135, GCST90264136, GCST90264137, GCST90264138, GCST90264139, GCST90264140, GCST90264141, GCST90264142, GCST90264143, GCST90264144, GCST90264145, GCST90264146, GCST90264147, GCST90264148, GCST90264149, and GCST90264150.

PubMed id: 37253732


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
204709/Z/16/ZWellcome Trust
203105/Z/16/ZWellcome Trust
Biotechnology and Biological Sciences Research Council (BBSRC)
L’Oreal UNESCO FWIS Award
G-2003
Medical Research Council (MRC)
Michael J Fox Foundation
MJFF-007574
MJFF-007690
MR/K026992/1
MR/T030852/1
Parkinson’s UK
University of Edinburgh
Wellcome Centre for Mitochondrial Research
Wellcome Trust

Share